PF-06743649

DRUG3 trials

Sponsors

Pfizer

Conditions

GoutHealthyHealthy Elderly

Phase 1

A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649

CompletedNCT02151617

Start: 2014-06-30End: 2014-12-31Updated: 2015-01-19

A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649

TerminatedNCT02170012

PfizerHealthy Elderly

Start: 2014-07-31End: 2014-09-30Updated: 2015-03-17

Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.

TerminatedNCT02187029

Start: 2014-07-31End: 2014-12-31Updated: 2016-11-11